ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Best Shares
Broker rates these 2 top ASX 200 shares as buys in July
Healthcare Shares
Why Goldman Sachs sees 13% upside for the ResMed share price
Investing Strategies
This is what I'd do with these 3 battered ASX shares: fund manager
Healthcare Shares
Goldman names 2 ASX healthcare shares to buy
Investing Strategies
2 ASX shares to benefit from strong US dollar: expert
Blue Chip Shares
Why I would invest $10,000 in these 3 ASX shares
Share Market News
ASX 200 midday update: ResMed's US$1bn acquisition, tech shares continue to sink
Mergers & Acquisitions
ResMed share price drops despite US$1bn Medifox Dan acquisition
Broker Notes
Broker tips ResMed share price to jump 19%
Healthcare Shares
Goldman Sachs names 3 ASX healthcare shares to buy
Share Market News
5 things to watch on the ASX 200 on Wednesday
Blue Chip Shares
Experts name 2 excellent blue chip ASX 200 shares to buy
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
